Unlocking Myasthenia Gravis Efficacy: Navigating Advanced Outcome Measures in Clinical Trials

Clinical TrialsTherapueticsFDA

Aug 18

Written By Corey Hubbard

GlassBury Cares Podcast

Episode #29

Myasthenia GravisResearchDr. Jan Lykke Scheel Thomsen

WIN378: Windward Bio's Long-Acting TSLP Antibody Poised to Transform Asthma & COPD Care

Nuvectis Pharma's Bold Pivot: NXP800 Exits Ovarian Cancer, NXP900 Leads New Oncology Frontier